文献速递炎症性肠病

重编程改变的色氨酸代谢作为炎症性肠病的新治疗策略

Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases.
PubMed 文献 · Gut · 2022-10-21

研究在1069例炎症性肠病(IBD)患者队列中开展靶向定量代谢组学,并结合小鼠结肠炎实验,发现肠道炎症严重程度与黄尿酸(XANA)和犬尿喹啉酸(KYNA)含量负相关。补充XANA或KYNA可通过激活芳香烃受体(AhR)和重编程细胞能量代谢减轻结肠炎,直接调节内源性色氨酸代谢的AADAT酶在啮齿类结肠炎模型中具有保护作用。

要点

  • IBD患者和小鼠中,肠道炎症严重程度与XANA和KYNA含量负相关。
  • 补充XANA或KYNA通过AhR激活和能量代谢重编程减轻结肠炎严重程度。
  • 使用重组酶AADAT调节内源性色氨酸代谢在啮齿类结肠炎模型中具有保护作用。

核心结论

  • 研究识别了色氨酸代谢与肠道炎症及IBD关联的新机制,恢复XANA和KYNA具有保护作用,涉及AhR和肠道上皮细胞及CD4+ T细胞能量代谢重编程。
  • 该研究为通过AADAT操纵内源性代谢途径以药理学纠正IBD代谢改变的新治疗策略铺平道路。

研究设计与样本

  • 在两个人IBD队列(1069例IBD患者)中开展靶向定量代谢组学。
  • 使用葡聚糖硫酸钠诱导的小鼠结肠炎实验评估已识别代谢物的效应。
  • 采用体外、离体和体内实验阐明机制,并通过包括单细胞代谢翻译抑制谱分析在内的多种方法评估能量代谢效应。

主要发现

  • 在小鼠和人类中,肠道炎症严重程度与黄尿酸(XANA)和犬尿喹啉酸(KYNA)的量负相关。
  • 补充XANA或KYNA通过影响肠道上皮细胞和T细胞降低结肠炎严重程度,涉及AhR激活和细胞能量代谢重编程。
  • 使用重组酶氨基己二酸氨基转移酶(AADAT)直接调节内源性色氨酸代谢在啮齿类结肠炎模型中具有保护作用。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The extent to which tryptophan (Trp) metabolism alterations explain or influence the outcome of inflammatory bowel diseases (IBDs) is still unclear. However, several Trp metabolism end-products are essential to intestinal homeostasis. Here, we investigated the role of metabolites from the kynurenine pathway. DESIGN: Targeted quantitative metabolomics was performed in two large human IBD cohorts (1069 patients with IBD). Dextran sodium sulphate-induced colitis experiments in mice were used to evaluate effects of identified metabolites. In vitro, ex vivo and in vivo experiments were used to decipher mechanisms involved. Effects on energy metabolism were evaluated by different methods including Single Cell mEtabolism by profiling Translation inHibition. RESULTS: In mice and humans, intestinal inflammation severity negatively correlates with the amount of xanthurenic (XANA) and kynurenic (KYNA) acids. Supplementation with XANA or KYNA decreases colitis severity through effects on intestinal epithelial cells and T cells, involving Aryl hydrocarbon Receptor (AhR) activation and the rewiring of cellular energy metabolism. Furthermore, direct modulation of the endogenous tryptophan metabolism, using the recombinant enzyme aminoadipate aminotransferase (AADAT), responsible for the generation of XANA and KYNA, was protective in rodent colitis models. CONCLUSION: Our study identified a new mechanism linking Trp metabolism to intestinal inflammation and IBD. Bringing back XANA and KYNA has protective effects involving AhR and the rewiring of the energy metabolism in intestinal epithelial cells and CD4+ T cells. This study paves the way for new therapeutic strategies aiming at pharmacologically correcting its alterations in IBD by manipulating the endogenous metabolic pathway with AADAT.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Michaudel C, Danne C, Agus A, et al. Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases. Gut. 2022. PMID: 36270778. doi:10.1136/gutjnl-2022-327337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。